OAM
MJN

Oppenheimer Asset Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Oppenheimer Asset Management’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,347
Closed -$120K – 1764
2017
Q1 		$120K Buy
+1,347
New +$111K ﹤0.01% 1150

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Oppenheimer Asset Management's MJN Position: Q2 2017 in Review

Oppenheimer Asset Management sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 1,347 shares — an estimated $120K sold.

Oppenheimer Asset Management first reported a position in MJN in Q1 2017 and held it in 1 quarter. The position peaked at $120K in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Oppenheimer Asset Management reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Oppenheimer Asset Management sold 1,347 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $120K.
  • Oppenheimer Asset Management first reported a position in Mead Johnson Nutrition Company in Q1 2017 and held it in 1 quarter.
  • Oppenheimer Asset Management's Mead Johnson Nutrition Company position peaked at $120K in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Oppenheimer Asset Management's 13F filing for Q2 2017, filed 9 Aug 2017.